Subjects included in the Non-CAD-group presented with an absolute copy number from TLR9 mRNA of 5,230e-005 (IQR 3,830e-005–6,700e-005) copies/μl after normalisation with beta-Actin, while patients with NSTEMI and STEMI presented with comparable amounts of mRNA (4,610e-005 (IQR 1,755e-005–8,560e-005); 5,150e-005 (IQR 3,400e-005–8,458e-005)). This evidence concerns the gene ACTB and coronary artery disorder.